vida: research 2026 04 29 #5642

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 06:58:47 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 06:59 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 06:59 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific data points like MSSP savings figures, GLP-1 coverage declines, and MHPAEA report findings, and the inbox files are source metadata, which are not subject to factual accuracy review in this context.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the journal entry details quantitative evidence from MSSP data and market trends that strengthen the belief.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific data points like MSSP savings figures, GLP-1 coverage declines, and MHPAEA report findings, and the inbox files are source metadata, which are not subject to factual accuracy review in this context. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the journal entry details quantitative evidence from MSSP data and market trends that strengthen the belief. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Session 2026-04-29 Research Journal Entry

Criterion-by-Criterion Evaluation

  1. Schema — All 11 files in inbox/queue/ are sources with source-appropriate frontmatter (no claim fields required); the research journal is a research document (not a claim file); no schema violations detected for any content type in this PR.

  2. Duplicate/redundancy — This is a research journal entry synthesizing 11 new sources into a disconfirmation analysis; no claims are being enriched in this PR, so no duplicate evidence injection is possible; the journal entry itself documents a new research session (Session 2026-04-29) that doesn't duplicate prior sessions.

  3. Confidence — No claim files are modified in this PR (only research journal and source ingestion), so confidence calibration does not apply; the journal entry documents confidence shifts for Vida's internal beliefs, which is appropriate for research documentation.

  4. Wiki links — No wiki links appear in the research journal entry or any of the 11 source files, so no broken links to evaluate.

  5. Source quality — The 11 sources include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, HCPlan industry data on VBC adoption, 9amHealth industry newsletter, and MHPAEA statutory reports; all sources are credible for healthcare policy/market analysis.

  6. Specificity — No claim files are being modified, so specificity evaluation of claim titles does not apply; the research journal entry makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted.

Additional Observations

The research journal entry is well-structured as a disconfirmation attempt with clear methodology (testing Belief 3 against market competition counter-argument), quantitative findings, and explicit confidence updates. The 11 source files provide documentary evidence for the claims made in the journal entry. This is research documentation, not knowledge base claim modification, so most claim-specific criteria don't apply.

# PR Review: Session 2026-04-29 Research Journal Entry ## Criterion-by-Criterion Evaluation 1. **Schema** — All 11 files in inbox/queue/ are sources with source-appropriate frontmatter (no claim fields required); the research journal is a research document (not a claim file); no schema violations detected for any content type in this PR. 2. **Duplicate/redundancy** — This is a research journal entry synthesizing 11 new sources into a disconfirmation analysis; no claims are being enriched in this PR, so no duplicate evidence injection is possible; the journal entry itself documents a new research session (Session 2026-04-29) that doesn't duplicate prior sessions. 3. **Confidence** — No claim files are modified in this PR (only research journal and source ingestion), so confidence calibration does not apply; the journal entry documents confidence shifts for Vida's internal beliefs, which is appropriate for research documentation. 4. **Wiki links** — No [[wiki links]] appear in the research journal entry or any of the 11 source files, so no broken links to evaluate. 5. **Source quality** — The 11 sources include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, HCPlan industry data on VBC adoption, 9amHealth industry newsletter, and MHPAEA statutory reports; all sources are credible for healthcare policy/market analysis. 6. **Specificity** — No claim files are being modified, so specificity evaluation of claim titles does not apply; the research journal entry makes falsifiable assertions (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings") that could be verified or contradicted. ## Additional Observations The research journal entry is well-structured as a disconfirmation attempt with clear methodology (testing Belief 3 against market competition counter-argument), quantitative findings, and explicit confidence updates. The 11 source files provide documentary evidence for the claims made in the journal entry. This is research documentation, not knowledge base claim modification, so most claim-specific criteria don't apply. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 07:00:30 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 07:00:30 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 07:02:32 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.